Momenta Pharmaceuticals
Biotechnology ResearchMassachusetts, United States51-200 Employees
Momenta Pharmaceuticals is a biotechnology company focused on discovering and developing therapeutics for rare, immune-mediated diseases. Its approach is grounded in immune biology and disease analytics, and is supported by protein engineering and antibody design capabilities, which have contributed to the development of several novel therapies for high-need conditions. The company is based in Cambridge, Massachusetts, and operates as a mid-sized player in the biotechnology research sector. Its target market consists of patients with immune-mediated diseases where treatment options remain limited, with the work aimed at delivering new therapeutic solutions. Within its industry, the company is positioned as a developer of novel immune-focused therapies rather than a contract research or service provider, leveraging its scientific platform to advance candidates. In 2025, media reports reference the company forming partnerships with automotive brands to develop driver-assistance technologies.